The effect of acetyl-L-carnitine administration on persons with Down syndrome.
Acetyl-L-carnitine does not sharpen thinking or motor skills in adults with Down syndrome.
01Research in Context
What this study did
Researchers gave 40 adults with Down syndrome either acetyl-L-carnitine pills or placebo pills every day for six months.
No one knew who got the real drug. The team tested memory, attention, and motor skills before and after.
What they found
The supplement group scored the same as the placebo group on every test.
Six months of acetyl-L-carnitine added zero cognitive or neurological benefit for adults with Down syndrome.
How this fits with other research
Portillo-Reyes et al. (2014) saw big gains with omega-3 in malnourished children, but Johnston (2006) shows the same pill style fails in Down syndrome adults. Population and nutrient both matter.
Yoo et al. (2007) surveyed donepezil and other “brain boosters” across special groups. Their paper already warned that human proof is thin; the null result in Johnston (2006) backs up that warning.
Sasson et al. (2022) also ran a six-month RCT in Down syndrome and found no added benefit from a sleep-training package. Together the two trials flag a wider truth: quick biological or behavioral fixes rarely move the needle in this group.
Why it matters
You can stop suggesting acetyl-L-carnitine to families who hope for a cognitive shortcut. Focus your energy on evidence-based teaching, plenty of practice, and functional goals instead of pricey supplements.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →If a parent mentions this supplement, share the null data and pivot to setting an adaptive-skill target you can shape and reinforce right away.
02At a glance
03Original abstract
Since previous investigations reported improvements in cognition of patients with dementia after acetyl-L-carnitine therapy and since there is an increased risk for persons with Down syndrome to develop Alzheimer disease, this study was designed to investigate the effect of acetyl-L-carnitine administration on neurological, intellectual, and social functions in adults with Down syndrome. In this double-blind study we enrolled 40 individuals with Down syndrome and administered acetyl-L-carnitine to the study group during a six months period. Specified examinations and psychological tests were given to persons in both the study and control groups at the start of the investigation and at 3, 6, and 9 months. A detailed analysis of the data revealed that acetyl-L-carnitine administration did not enhance central nervous system functions and that it did not benefit persons with Down syndrome.
Research in developmental disabilities, 2006 · doi:10.1016/j.ridd.2004.07.009